Filing metadata

Accession number
0001209191-21-017876
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Mar 04, 2021
Reporting period
Mar 02, 2021
Description
Insider transaction

Explore SEC Filings Hub